Heart Inflammation and Mental Stress Study
HIMS
2 other identifiers
interventional
52
1 country
1
Brief Summary
The aim of the study is to investigate the neural underpinnings of cardiovascular reactivity to mental stress as a function of HIV and hypertensive risk.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Aug 2019
Longer than P75 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2018
CompletedFirst Posted
Study publicly available on registry
October 3, 2018
CompletedStudy Start
First participant enrolled
August 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2023
CompletedFebruary 15, 2024
February 1, 2024
4.3 years
September 28, 2018
February 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in heart rate variability
Heart rate variability will be measured using a standard electrocardiogram to detect variability in R -to-R intervals.
Baseline, pre-intervention and up to 60 minutes post-intervention
Secondary Outcomes (1)
Change in cytokine expression in peripheral blood mononuclear cells
Baseline, pre-intervention and up to 60 minutes post-intervention
Study Arms (3)
Paced breathing
EXPERIMENTALIndividuals will be asked to sit in a quiet room while sensors collect their heart rate, respiratory rate and blood pressure for approximately 45 minutes. Individuals in this arm will engage in a paced breathing. Initial respiratory rate will be measured with a transducer. Participants will be connected to a paced breathing device (RESPERATE) that will gradually reduce the pace of audio tones presented to those individuals from spontaneous breathing rate down to 6 - 8 breaths per minute.
Relaxing music
ACTIVE COMPARATORIndividuals will be asked to sit in a quiet room while sensors collect their heart rate, respiratory rate and blood pressure for approximately 45 minutes. Individuals will be provided with an audio device that plays soothing/relaxing music at a similar range (beats per minute) of the auditory signal presented during the experimental condition. Subjects will not be instructed how to breathe in this arm.
No intervention
NO INTERVENTIONIndividuals will be asked to sit in a quiet room while sensors collect their heart rate, respiratory rate and blood pressure for approximately 45 minutes.
Interventions
Individuals will be fitted with a respiratory transducer and receive auditory tones with which to pace their rate of inspiration and expiration in the experimental group.
Individuals will be provided with headphones while resting quietly listening to relaxing tones/music.
Eligibility Criteria
You may qualify if:
- pre-hypertension screening.
- HIV-antibody testing.
You may not qualify if:
- current use of anti-lipid, antihypertensive, or heart rate altering medications;
- current or lifetime history of cardiovascular disease diagnosis or treatment including pulmonary stenosis, heart valve abnormalities and hypertension;
- current or lifetime diagnoses of cancer, kidney/liver disease, hypertension, Type 1 or Type 2 diabetes;
- history of trauma, cerebral infarction or hemorrhage;
- current diagnosis and/or treatment for hypertension;
- severe cognitive impairment;
- current treatment or diagnosis of psychiatric illness;
- metal implants or debris within the body; or pregnancy;
- body mass index \> 35;
- use of hormone replacement therapy; and current smoker.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Miami
Miami, Florida, 33136, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roger C McIntosh, Ph.D.
University of Miami, College of Arts and Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 28, 2018
First Posted
October 3, 2018
Study Start
August 19, 2019
Primary Completion
December 1, 2023
Study Completion
December 22, 2023
Last Updated
February 15, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share